MedPath

To evaluate the analgesic efficacy of transmuscular quadratus lumborum block in percutaneous nephrolithotomy

Recruiting
Conditions
Urinary calculus, unspecified,
Registration Number
CTRI/2022/12/047972
Lead Sponsor
Baraniya Pandirajan
Brief Summary

Randomised double-blinded study- Transmucular quadratus lumborum block QL3(20ml of 0.25% Bupivacaine in Group A,20ml of saline in Group B) in percutaneous nephrolithotomy to measure postoperative requirement of analgesic Inj.Tramadol

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
66
Inclusion Criteria

Patient age >18yrs ASA status 1,2 Elective percutaneous nephrolithotomy.

Exclusion Criteria

Refusal to participate in the study Age <18yrs ASA 4 & 5 Known coagulation disorder Allergy to local Anaesthetics Unconscious or mentally incompetent Pregnancy & hemodynamic instability.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare 2 groups,0h(immediate post extubation);15min,1h,2h,4h,6h,8h,14h,20h,24h
Cumulative tramadol consumption.0h(immediate post extubation);15min,1h,2h,4h,6h,8h,14h,20h,24h
Secondary Outcome Measures
NameTimeMethod
Assessing theanalgesic efficacy of quadratus lumborum block postoperativelyAssessing theanalgesic efficacy of quadratus lumborum block postoperatively at 15mins,1hr,2hr in PACU and every 2nd hourly for 8hr and every 6th hourly for 24hours
to observe the changes in hemodynamic parameters intraoperatively such as heart rate,systolic and diastolic blood pressure

Trial Locations

Locations (1)

Sri Ramachandra institute of higher education and research

🇮🇳

Kancheepuram, TAMIL NADU, India

Sri Ramachandra institute of higher education and research
🇮🇳Kancheepuram, TAMIL NADU, India
Baraniya
Principal investigator
9952994875
baru231995@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.